Show simple item record

dc.contributor.authorEwald, F
dc.contributor.authorUeffing, N
dc.contributor.authorBrockmann, L
dc.contributor.authorHader, C
dc.contributor.authorTelieps, T
dc.contributor.authorSchuster, M
dc.contributor.authorSchulz, W A
dc.contributor.authorSchmitz, I
dc.date.accessioned2012-05-15T14:32:46Z
dc.date.available2012-05-15T14:32:46Z
dc.date.issued2011
dc.identifier.citationThe role of c-FLIP splice variants in urothelial tumours. 2011, 2:e245 Cell Death Disen_GB
dc.identifier.issn2041-4889
dc.identifier.pmid22190004
dc.identifier.doi10.1038/cddis.2011.131
dc.identifier.urihttp://hdl.handle.net/10033/223832
dc.description.abstractDeregulation of apoptosis is common in cancer and is often caused by overexpression of anti-apoptotic proteins in tumour cells. One important regulator of apoptosis is the cellular FLICE-inhibitory protein (c-FLIP), which is overexpressed, for example, in melanoma and Hodgkin's lymphoma cells. Here, we addressed the question whether deregulated c-FLIP expression in urothelial carcinoma impinges on the ability of death ligands to induce apoptosis. In particular, we investigated the role of the c-FLIP splice variants c-FLIP(long) (c-FLIP(L)) and c-FLIP(short) (c-FLIP(S)), which can have opposing functions. We observed diminished expression of the c-FLIP(L) isoform in urothelial carcinoma tissues as well as in established carcinoma cell lines compared with normal urothelial tissues and cells, whereas c-FLIP(S) was unchanged. Overexpression and RNA interference studies in urothelial cell lines nevertheless demonstrated that c-FLIP remained a crucial factor conferring resistance towards induction of apoptosis by death ligands CD95L and TRAIL. Isoform-specific RNA interference showed c-FLIP(L) to be of particular importance. Thus, urothelial carcinoma cells appear to fine-tune c-FLIP expression to a level sufficient for protection against activation of apoptosis by the extrinsic pathway. Therefore, targeting c-FLIP, and especially the c-FLIP(L) isoform, may facilitate apoptosis-based therapies of bladder cancer in otherwise resistant tumours.
dc.language.isoenen
dc.rightsArchived with thanks to Cell death & diseaseen_GB
dc.subject.meshAgeden_GB
dc.subject.meshAged, 80 and overen_GB
dc.subject.meshAntineoplastic Agentsen_GB
dc.subject.meshApoptosisen_GB
dc.subject.meshCASP8 and FADD-Like Apoptosis Regulating Proteinen_GB
dc.subject.meshCell Line, Tumoren_GB
dc.subject.meshCycloheximideen_GB
dc.subject.meshFemaleen_GB
dc.subject.meshHumansen_GB
dc.subject.meshMaleen_GB
dc.subject.meshMiddle Ageden_GB
dc.subject.meshProtein Isoformsen_GB
dc.subject.meshRNA Interferenceen_GB
dc.subject.meshRNA Splicingen_GB
dc.subject.meshRNA, Messengeren_GB
dc.subject.meshRNA, Small Interferingen_GB
dc.subject.meshTNF-Related Apoptosis-Inducing Liganden_GB
dc.subject.meshUrinary Bladder Neoplasmsen_GB
dc.titleThe role of c-FLIP splice variants in urothelial tumours.en
dc.typeArticleen
dc.contributor.departmentInstitute of Molecular and Clinical Immunology, Otto-von-Guericke-University Magdeburg and Department of Immune Control, Helmholtz Centre for Infection Research, D-38124 Braunschweig, Germany.en_GB
dc.identifier.journalCell death & diseaseen_GB
refterms.dateFOA2018-06-13T05:29:59Z
html.description.abstractDeregulation of apoptosis is common in cancer and is often caused by overexpression of anti-apoptotic proteins in tumour cells. One important regulator of apoptosis is the cellular FLICE-inhibitory protein (c-FLIP), which is overexpressed, for example, in melanoma and Hodgkin's lymphoma cells. Here, we addressed the question whether deregulated c-FLIP expression in urothelial carcinoma impinges on the ability of death ligands to induce apoptosis. In particular, we investigated the role of the c-FLIP splice variants c-FLIP(long) (c-FLIP(L)) and c-FLIP(short) (c-FLIP(S)), which can have opposing functions. We observed diminished expression of the c-FLIP(L) isoform in urothelial carcinoma tissues as well as in established carcinoma cell lines compared with normal urothelial tissues and cells, whereas c-FLIP(S) was unchanged. Overexpression and RNA interference studies in urothelial cell lines nevertheless demonstrated that c-FLIP remained a crucial factor conferring resistance towards induction of apoptosis by death ligands CD95L and TRAIL. Isoform-specific RNA interference showed c-FLIP(L) to be of particular importance. Thus, urothelial carcinoma cells appear to fine-tune c-FLIP expression to a level sufficient for protection against activation of apoptosis by the extrinsic pathway. Therefore, targeting c-FLIP, and especially the c-FLIP(L) isoform, may facilitate apoptosis-based therapies of bladder cancer in otherwise resistant tumours.


Files in this item

Thumbnail
Name:
Ewald et al_final.pdf
Size:
791.3Kb
Format:
PDF
Description:
Open Access publication

This item appears in the following Collection(s)

Show simple item record